JPS61246232A - ポルフィリンポリマーの製造法 - Google Patents
ポルフィリンポリマーの製造法Info
- Publication number
- JPS61246232A JPS61246232A JP60085439A JP8543985A JPS61246232A JP S61246232 A JPS61246232 A JP S61246232A JP 60085439 A JP60085439 A JP 60085439A JP 8543985 A JP8543985 A JP 8543985A JP S61246232 A JPS61246232 A JP S61246232A
- Authority
- JP
- Japan
- Prior art keywords
- hpd
- polymer
- solution
- porphyrin
- porphyrin polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 37
- 150000004032 porphyrins Chemical class 0.000 title claims abstract description 32
- 239000000126 substance Substances 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract description 27
- 206010028980 Neoplasm Diseases 0.000 abstract description 23
- 201000011510 cancer Diseases 0.000 abstract description 19
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 8
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 abstract description 7
- 238000003745 diagnosis Methods 0.000 abstract description 7
- 239000003960 organic solvent Substances 0.000 abstract description 7
- 238000010438 heat treatment Methods 0.000 abstract description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 5
- 229960003569 hematoporphyrin Drugs 0.000 abstract description 5
- 239000001301 oxygen Substances 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 5
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 abstract description 3
- 206010034972 Photosensitivity reaction Diseases 0.000 abstract description 3
- 229950003776 protoporphyrin Drugs 0.000 abstract description 3
- 230000036211 photosensitivity Effects 0.000 abstract description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract description 2
- 230000007717 exclusion Effects 0.000 abstract 1
- 150000004033 porphyrin derivatives Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 34
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 239000003504 photosensitizing agent Substances 0.000 description 13
- 239000002244 precipitate Substances 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 238000000108 ultra-filtration Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000035567 cellular accumulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 101150107276 hpd-1 gene Proteins 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polyethers (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60085439A JPS61246232A (ja) | 1985-04-23 | 1985-04-23 | ポルフィリンポリマーの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60085439A JPS61246232A (ja) | 1985-04-23 | 1985-04-23 | ポルフィリンポリマーの製造法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61116254A Division JPS6263586A (ja) | 1986-05-22 | 1986-05-22 | ポルフイリンポリマ− |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61246232A true JPS61246232A (ja) | 1986-11-01 |
| JPH0554489B2 JPH0554489B2 (enrdf_load_stackoverflow) | 1993-08-12 |
Family
ID=13858890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60085439A Granted JPS61246232A (ja) | 1985-04-23 | 1985-04-23 | ポルフィリンポリマーの製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61246232A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1308481A3 (en) * | 1992-08-14 | 2004-04-28 | The Trustees Of The University Of Pennsylvania | Metal-mediated cross-coupling with ring-metalated porphyrins |
-
1985
- 1985-04-23 JP JP60085439A patent/JPS61246232A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1308481A3 (en) * | 1992-08-14 | 2004-04-28 | The Trustees Of The University Of Pennsylvania | Metal-mediated cross-coupling with ring-metalated porphyrins |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0554489B2 (enrdf_load_stackoverflow) | 1993-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69922216T2 (de) | Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte | |
| EP0120054B1 (en) | Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method | |
| CN100381444C (zh) | 酞菁硅配合物及其复合物以及它们的制备和应用 | |
| CN110003461B (zh) | 多碘修饰的氟硼二吡咯类衍生物及其制备方法和应用 | |
| CN1011571B (zh) | 可用于治疗肿瘤的一种药物的制备方法 | |
| CN109796483B (zh) | 一种水溶性阳离子型光敏剂及其制备和应用 | |
| CN113683602A (zh) | 一种用于缺氧肿瘤多模态治疗的七甲川花菁小分子和制备方法及应用 | |
| CN104844645B (zh) | 一种轴向ala修饰的硅酞菁及其制备方法和应用 | |
| EP1066293A2 (de) | Porphyrine und ihre verwendung als photosensitizer | |
| KR101643295B1 (ko) | 폴리실세스퀴옥산을 코어로 하는 수용성 포르피린집합체 광감작제 및 그 제조방법 | |
| CN104650129B (zh) | 一种轴向酯键连接哌啶或吗啉衍生物的硅酞菁 | |
| US20030134824A1 (en) | Beta-cyclodextrin dimers and phthalocyanines and uses thereof | |
| CN112409365A (zh) | 3-磺酸基丙烷巯基修饰酞菁及其制备方法与在制药领域的应用 | |
| JPS61246232A (ja) | ポルフィリンポリマーの製造法 | |
| JPS6263586A (ja) | ポルフイリンポリマ− | |
| JPH0466873B2 (enrdf_load_stackoverflow) | ||
| JPS62167783A (ja) | ポルフイリン誘導体 | |
| JPH0786109B2 (ja) | フェオフォルバイド誘導体 | |
| WO2001040234A1 (fr) | Compose porphyrine | |
| US5789586A (en) | Efficient functionalization of porphyrin derivatives possessing sulfonic acid groups | |
| JP3718887B2 (ja) | ポルフィリン誘導体とその用途 | |
| CN1193793C (zh) | 二芳基卟吩类光敏剂及其制备方法和用途 | |
| CN111135298A (zh) | 一种双亲性氟硼二吡咯类化合物及其制备方法和用途 | |
| CN113717183B (zh) | 周环不对称精氨酸修饰酞菁及其制备和在制药领域的应用 | |
| CN119463201B (zh) | 一种纳米诊疗平台的制备方法和应用 |